KRAS gene status in gastric signet-ring cell carcinoma patients and act as biomarker of MEK inhibitor
Por:
Wu, ND, Huang, Y, Fan, XS, Yang, Y, Liu, Q, Yu, LX, Rosell, R, Liu, BR and Wei, J
Publicada:
1 jul 2019
Resumen:
Filiaciones:
Wu, ND:
Nanjing Univ, Ctr Comprehens Canc, Drum Tower Hosp, Sch Med, Nanjing, Jiangsu, Peoples R China
Nanjing Univ, Clin Canc Inst, Nanjing, Jiangsu, Peoples R China
Huang, Y:
Nanjing Univ, Ctr Comprehens Canc, Drum Tower Hosp, Sch Med, Nanjing, Jiangsu, Peoples R China
Nanjing Univ, Clin Canc Inst, Nanjing, Jiangsu, Peoples R China
Fan, XS:
Nanjing Univ, Dept Pathol, Drum Tower Hosp, Sch Med, Nanjing, Jiangsu, Peoples R China
Yang, Y:
Nanjing Univ, Ctr Comprehens Canc, Drum Tower Hosp, Sch Med, Nanjing, Jiangsu, Peoples R China
Nanjing Univ, Clin Canc Inst, Nanjing, Jiangsu, Peoples R China
Liu, Q:
Nanjing Univ, Ctr Comprehens Canc, Drum Tower Hosp, Sch Med, Nanjing, Jiangsu, Peoples R China
Nanjing Univ, Clin Canc Inst, Nanjing, Jiangsu, Peoples R China
Yu, LX:
Nanjing Univ, Ctr Comprehens Canc, Drum Tower Hosp, Sch Med, Nanjing, Jiangsu, Peoples R China
Nanjing Univ, Clin Canc Inst, Nanjing, Jiangsu, Peoples R China
:
Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, Badalona, Spain
Liu, BR:
Nanjing Univ, Ctr Comprehens Canc, Drum Tower Hosp, Sch Med, Nanjing, Jiangsu, Peoples R China
Nanjing Univ, Clin Canc Inst, Nanjing, Jiangsu, Peoples R China
Wei, J:
Nanjing Univ, Ctr Comprehens Canc, Drum Tower Hosp, Sch Med, Nanjing, Jiangsu, Peoples R China
Nanjing Univ, Clin Canc Inst, Nanjing, Jiangsu, Peoples R China
|